AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 25807814
Drug: Syndrome Differentiated
RxNorm normalized name: Syndros
DrugBank: Dronabinol (DB00470)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Syndrome Differentiated Chinese Medicine Therapy
Trial: 11673752
Drug: Losartan 50
RxNorm normalized name: LOSARTAN 50MG TAB
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Losartan 50 mg/d
Trial: 21834863
Drug: Screw-retained implant-supported
RxNorm normalized name: betaine
DrugBank: Betaine (DB06756)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Screw-retained implant-supported full-arch casted titanium-resin prostheses
Trial: 10759235
Drug: IFN‐alpha2b, 5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: IFN‐alpha2b, 5 MU daily plus ribavirin
Trial: 1569815
Drug: 13‐RED regimen
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 13‐RED regimen (twice weekly rifampicin 600 mg, daily ethionamide 500 mg, dapsone 100 mg)
Trial: 1569815
Drug: Reduced dosage
RxNorm normalized name: osage orange pollen extract
DrugBank: Maclura pomifera pollen (DB10988)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Reduced dosage of ethionamide to 5 mg/k bodyweight in the RED group
Trial: 1569815
Drug: REC regimen
RxNorm normalized name: Anacin Aspirin Regimen Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: REC regimen (clofazimine 100 mg)
Trial: 6339294
Drug: halometasone/triclosan cream
FDA approved: no
EMA approved: no
PMDA approved: no
Description: halometasone/triclosan cream
Trial: 6339294
Drug: fluocinolone acetonide/neomycin
RxNorm normalized name: Fluocinolone Acetonide/Neomycin Sulfate 0.025%-0.5% Topical application Cream
FDA approved: no
EMA approved: no
PMDA approved: no
Description: fluocinolone acetonide/neomycin cream
Trial: 6339294
Drug: fluprednylidene acetate/gentamicin/chlorohydroxyquinoline
FDA approved: no
EMA approved: no
PMDA approved: no
Description: fluprednylidene acetate/gentamicin/chlorohydroxyquinoline cream
Trial: 25223482
Drug: Epirubicin/cyclophosphamide followed
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Epirubicin/cyclophosphamide followed by docetaxel with bevacizumab (8 infusions every 3 weeks)
Trial: 25223482
Drug: Paclitaxel with
RxNorm normalized name: Paclitaxel
DrugBank: Paclitaxel (DB01229)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Paclitaxel with everolimus (5 mg/day)
Trial: 15383197
Drug: 500 mg
RxNorm normalized name: bran 500 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 500 mg levofloxacin
Trial: 15774257
Drug: 320/1600 mg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 320/1600 mg trimethoprim/sulfamethoxazole (TMP/SMZ)
Trial: 11432680
Drug: No antibiotic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No antibiotic prophylaxis (control group)
Trial: 9660087
Drug: hCG/human menopausal
FDA approved: no
EMA approved: no
PMDA approved: no
Description: hCG/human menopausal gonadotropin treatment in IHH patients
Trial: 9660087
Drug: Testosterone treatment
RxNorm normalized name: Testosterone
DrugBank: (1,2,6,7-3H)Testosterone (DB14093)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Testosterone treatment in Klinefelter's syndrome patients
Trial: 2515720
Drug: Selegiline 10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Selegiline 10 mg per day
Trial: 24403903
Drug: Red wine
RxNorm normalized name: Red wine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Red wine (100 ml for women, 200 ml for men daily)
Trial: 21450674
Drug: Simvastatin 20
RxNorm normalized name: simvastatin 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Simvastatin 20 or 40 mg
Trial: 21450674
Drug: Participants reaching
RxNorm normalized name: cetylpyridinium chloride Mouthwash [Breath-Away]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Participants reaching 2.0 mmol/l LDL-C
Trial: 19335418
Drug: Tacrolimus 0.03%
RxNorm normalized name: TACROLIMUS 0.03% OINT,TOP
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tacrolimus 0.03% ointment (once-daily application)
Trial: 19335418
Drug: Tacrolimus 0.03%
RxNorm normalized name: TACROLIMUS 0.03% OINT,TOP
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tacrolimus 0.03% ointment (twice-daily application)
Trial: 15236620
Drug: Amprenavir (APV)
DrugBank: Amprenavir (DB00701)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Amprenavir (APV) boosted with low-dose ritonavir (RTV, 100 mg bid)
Trial: 15236620
Drug: Standard of
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard of care (SOC) protease inhibitors (PIs) with or without low-dose RTV
Trial: 30314506
Drug: Conservative TMD
RxNorm normalized name: Conserved dopamine neurotrophic factor
DrugBank: HER-902 (DB17948)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conservative TMD treatment with a maximum of 18 sessions within 9 weeks
Trial: 30314506
Drug: Delayed-start group
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Delayed-start group (no treatment for 9 weeks)
Trial: 21377273
Drug: ABT-102 4
RxNorm normalized name: ABT-925
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ABT-102 4 mg twice a day
Trial: 18755719
Drug: GEWF solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: GEWF solution preparation
Trial: 14693069
Drug: Adjuvant chemotherapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Adjuvant chemotherapy based on chemosensitivity testing in nude mouse assay (Group I)
Trial: 14693069
Drug: Standard regimen
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard regimen adjuvant chemotherapy (Group C) - cyclophosphamide (CTX) 600 mg/m² d1 + Adriamycin (ADM) 40 mg/m² d1 + cisplatin (DDP) 20 mg/m² d1-5
Trial: 8642852
Drug: Idarubicin (IDA:
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Idarubicin (IDA: 8 mg/m2/day, i.v. bolus for 5 days)
Trial: 8642852
Drug: Daunorubicin (DNR:
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Daunorubicin (DNR: 50 mg/m2/day, i.v. bolus for 3 days)
Trial: 23517382
Drug: Autologous noncultured
RxNorm normalized name: Autologous cultured fibroblasts
DrugBank: Azficel-T (DB11051)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Autologous noncultured extracted hair follicle outer root sheath cell suspension (NCORSHFS)
Trial: 20528823
Drug: Naltrexone (50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Naltrexone (50 mg/d for 3 days)
Trial: 19059570
Drug: Weekly self-monitoring
RxNorm normalized name: tobramycin
DrugBank: Tobramycin (DB00684)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Weekly self-monitoring of INR (group B)
Trial: 19059570
Drug: Monthly laboratory
RxNorm normalized name: tobramycin
DrugBank: Tobramycin (DB00684)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Monthly laboratory monitoring (group A)
Trial: 19141327
Drug: Ciclesonide 160
RxNorm normalized name: CICLESONIDE 160MCG 60D ORAL INHL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ciclesonide 160 microg once daily
Trial: 12860365
Drug: Intramuscular olanzapine
RxNorm normalized name: Olanzapine
DrugBank: Olanzapine (DB00334)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intramuscular olanzapine (2.5-10 mg/injection)
Trial: 12860365
Drug: Intramuscular haloperidol
RxNorm normalized name: Haloperidol
DrugBank: Haloperidol (DB00502)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intramuscular haloperidol (7.5 mg/injection)
Trial: 11028256
Drug: terazosin 1,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: terazosin 1, 2, and 5 mg
Trial: 11028256
Drug: terazosin 2,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: terazosin 2, 5, and 10 mg
Trial: 11028256
Drug: terazosin 20,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: terazosin 20, 40, and 80 mg
Trial: 9365347
Drug: Elbow antagonists
RxNorm normalized name: Interleukin-1 receptor antagonist anakinra
DrugBank: Anakinra (DB00026)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Elbow antagonists reversal exercise
Trial: 1458667
Drug: 0.25% amorolfine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.25% amorolfine cream
Trial: 1458667
Drug: 1% bifonazole
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1% bifonazole cream
Trial: 22419860
Drug: Iron isomaltoside
RxNorm normalized name: Iron isomaltoside 1000
DrugBank: Iron isomaltoside 1000 (DB12208)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Iron isomaltoside 1000 (100 mg)
Trial: 22419860
Drug: Iron isomaltoside
RxNorm normalized name: Iron isomaltoside 1000
DrugBank: Iron isomaltoside 1000 (DB12208)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Iron isomaltoside 1000 (200 mg)
Trial: 10925438
Drug: Methyl methacrylate
RxNorm normalized name: METHYL METHACRYLATE
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Methyl methacrylate implants
Trial: 3086991
Drug: Rectal cultures
RxNorm normalized name: casein, emmental cultured
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rectal cultures
Trial: 30075711
Drug: IRIS intervention
FDA approved: no
EMA approved: no
PMDA approved: no
Description: IRIS intervention (Identification and Referral to Improve Safety) implemented in general practices; details on dosage and duration not specified.
Trial: 17934527
Drug: Neuropsychological group
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Neuropsychological group therapy
Trial: 16516083
Drug: rHDL containing
RxNorm normalized name: fish oil (containing omega-3 acids) Injection [Omegaven]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: rHDL containing low- or high-dose AIM
Trial: 12663588
Drug: Magnesium supplementation
RxNorm normalized name: Magnesium
DrugBank: Magnesium (DB14513)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Magnesium supplementation (50 ml MgCl(2) solution daily for 16 weeks)
Trial: 9315990
Drug: Clonazepam 0.5
RxNorm normalized name: clonazepam 0.5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Clonazepam 0.5 mg
Trial: 9315990
Drug: Clonazepam 1.0
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Clonazepam 1.0 mg
Trial: 9315990
Drug: Clonazepam 2.0
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Clonazepam 2.0 mg
Trial: 9315990
Drug: Clonazepam 3.0
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Clonazepam 3.0 mg
Trial: 9315990
Drug: Clonazepam 4.0
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Clonazepam 4.0 mg
Trial: 2879477
Drug: tertatolol 5
RxNorm normalized name: tertatolol 5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: tertatolol 5 mg
Trial: 27234658
Drug: Oxycodone 30mg
RxNorm normalized name: oxycodone hydrochloride 30 MG [Roxicodone]
DrugBank: Oxycodone (DB00497)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Oxycodone 30mg
Trial: 27234658
Drug: Oxycodone 60mg
RxNorm normalized name: oxycodone hydrochloride 60 MG
DrugBank: Oxycodone (DB00497)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Oxycodone 60mg
Trial: 23378299
Drug: Low high-density
RxNorm normalized name: high-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low high-density lipoprotein cholesterol and insulin resistance phenotype
Trial: 19801149
Drug: Placebo +
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo + Pravastatin (20 mg)
Trial: 19801149
Drug: Co-therapy with
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Co-therapy with Pravastatin
Trial: 18507667
Drug: Test group
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Test group 1 (conventional drill preparation with immediate functional loading)
Trial: 18507667
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (standard preparation procedure with submerged healing)
Trial: 20546215
Drug: ingenol mebutate
RxNorm normalized name: Ingenol Mebutate
DrugBank: Ingenol mebutate (DB05013)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: ingenol mebutate gel, 0.05% (Arm A)
Trial: 20546215
Drug: ingenol mebutate
RxNorm normalized name: Ingenol Mebutate
DrugBank: Ingenol mebutate (DB05013)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: ingenol mebutate gel, 0.0025% or 0.01% (Arm A)
Trial: 20546215
Drug: vehicle gel
RxNorm normalized name: vehicle gel base no.61
FDA approved: no
EMA approved: no
PMDA approved: no
Description: vehicle gel (Arm A and B)
Trial: 20546215
Drug: ingenol mebutate
RxNorm normalized name: Ingenol Mebutate
DrugBank: Ingenol mebutate (DB05013)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: ingenol mebutate gel (Arm A)
Trial: 16218171
Drug: IFN monotherapy
RxNorm normalized name: IFNγ
DrugBank: Interferon Gamma (DB15753)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: IFN monotherapy (9 MU IFN‐alpha2a three times weekly)
Trial: 16218171
Drug: IFN plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: IFN plus RBV (1000‐1200 mg/day)
Trial: 26918700
Drug: Controlled limited
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Controlled limited formula (10 ml formula by syringe after each breastfeeding, discontinued at onset of lactation)
Trial: 24202399
Drug: Hypokalemia interventions
RxNorm normalized name: hydroquinone
DrugBank: Hydroquinone (DB09526)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Hypokalemia interventions administered pre-admission and post-operative
Trial: 20693353
Drug: Aliskiren (150
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aliskiren (150 mg daily titrated to 300 mg daily after 3 months) added to 100 mg losartan
Trial: 20693353
Drug: Placebo added
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo added to 100 mg losartan
Trial: 16904417
Drug: DMPA‐SC 104
FDA approved: no
EMA approved: no
PMDA approved: no
Description: DMPA‐SC 104 (104 mg/0.65 ml subcutaneous injection)
Trial: 16904417
Drug: DMPA‐IM (intramuscular
FDA approved: no
EMA approved: no
PMDA approved: no
Description: DMPA‐IM (intramuscular injection)
Trial: 12534404
Drug: Etoricoxib (120
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Etoricoxib (120 mg once daily)
Trial: 12534404
Drug: Ibuprofen (800
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ibuprofen (800 mg t.d.s.)
Trial: 12848634
Drug: Naproxen (500
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Naproxen (500 mg b.d.)
Trial: 10491346
Drug: Nabumetone (1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nabumetone (1 g)
Trial: 7049706
Drug: Indapamide (2.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Indapamide (2.5 mg daily)
Trial: 29596040
Drug: Antibiotic agents
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antibiotic agents after I&D
Trial: 24368224
Drug: Emtricitabine (FTC)
RxNorm normalized name: Emtricitabine
DrugBank: Emtricitabine (DB00879)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Emtricitabine (FTC) 200 mg + Tenofovir disoproxil fumarate (TDF) 300 mg
Trial: 22327492
Drug: HPV-16/18 AS04-adjuvanted
FDA approved: no
EMA approved: no
PMDA approved: no
Description: HPV-16/18 AS04-adjuvanted vaccine (Cervarix)
Trial: 18772704
Drug: Moderate-dose bifrontal
RxNorm normalized name: Bos taurus frontal lobe preparation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Moderate-dose bifrontal ECT (BF)
Trial: 18772704
Drug: Low-dose bitemporal
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose bitemporal ECT (BT)
Trial: 9071516
Drug: LNG ROD
FDA approved: no
EMA approved: no
PMDA approved: no
Description: LNG ROD implants
Trial: 9071516
Drug: Norplant-2 implants
RxNorm normalized name: Norplant 3-oxime
DrugBank: Norelgestromin (DB06713)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Norplant-2 implants
Trial: 2941770
Drug: Zimelidine (100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Zimelidine (100 mg)
Trial: 2941770
Drug: Maprotiline (75
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Maprotiline (75 mg)
Trial: 22157519
Drug: Olmesartan 40
RxNorm normalized name: HCTZ 25/OLMESARTAN 40MG TAB
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Olmesartan 40 mg per day
Trial: 18000167
Drug: 5-drug induction
RxNorm normalized name: human sputum, Bordetella pertussis infected
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5-drug induction combination (including idarubicin, fludarabine, interleukin-2)
Trial: 18000167
Drug: 5-drug reinduction
RxNorm normalized name: REDUCTIC ACID
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5-drug reinduction
Trial: 98128
Drug: 4 mg
RxNorm normalized name: lutein 4 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 4 mg protirelin per day for 14 days
Trial: 27036394
Drug: Extended-release niacin
RxNorm normalized name: niacin Extended Release Oral Capsule
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Extended-release niacin (ERN) plus simvastatin/ezetimibe
Trial: 15649828
Drug: Total glycoalkaloid
RxNorm normalized name: Colgate Total Mouthwash
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Total glycoalkaloid (TGA) doses of 0.30 mg/kg BW
Trial: 15649828
Drug: Total glycoalkaloid
RxNorm normalized name: Colgate Total Mouthwash
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Total glycoalkaloid (TGA) doses of 0.50 mg/kg BW
Trial: 15649828
Drug: Total glycoalkaloid
RxNorm normalized name: Colgate Total Mouthwash
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Total glycoalkaloid (TGA) doses of 0.70 mg/kg BW
Trial: 15649828
Drug: Mashed potatoes
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mashed potatoes with TGA doses of 0.95 mg/kg BW
Trial: 15649828
Drug: Mashed potatoes
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mashed potatoes with TGA doses of 1.10 mg/kg BW
Trial: 15649828
Drug: Mashed potatoes
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mashed potatoes with TGA doses of 1.25 mg/kg BW
Trial: 12678198
Drug: Trimetazidine (TMZ)
RxNorm normalized name: trimetazidine
DrugBank: Trimetazidine (DB09069)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Trimetazidine (TMZ) plus dexrazoxane (DEX) (60 mg, daily dose)
Trial: 9231815
Drug: Enalapril (20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Enalapril (20 mg BID)
Trial: 9231815
Drug: Nifedipine (60
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nifedipine (60 mg OD)
Trial: 2259927
Drug: Oral tamoxifen
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral tamoxifen citrate 10 mg twice daily
Trial: 2259927
Drug: Oral megestrol
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral megestrol acetate 40 mg four times a day
Trial: 7402688
Drug: Histamine infusion
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Histamine infusion at 0.16, 0.33, and 0.66 microgram/kg/min
Trial: 7082501
Drug: Histamine infusion
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Histamine infusion
Trial: 7402688
Drug: H1 blocking
RxNorm normalized name: Ivy Block
FDA approved: no
EMA approved: no
PMDA approved: no
Description: H1 blocking agent (mepyramine)
Trial: 6357892
Drug: Alclometasone dipropionate
RxNorm normalized name: Alclometasone Dipropionate
DrugBank: Alclometasone (DB00240)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Alclometasone dipropionate cream 0.05%
Trial: 6389385
Drug: Clobetasone butyrate
RxNorm normalized name: clobetasone butyrate
FDA approved: no
EMA approved: no
PMDA approved: yes
Description: Clobetasone butyrate cream 0.05%
Trial: 27015295
Drug: Conventional combination
RxNorm normalized name: combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional combination treatment (sulfasalazine plus hydroxychloroquine)
Trial: 22378918
Drug: Lithium carbonate
RxNorm normalized name: Lithium Carbonate
DrugBank: Lithium carbonate (DB14509)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Lithium carbonate (target blood level 0.4‐0.8 mEq/l)
Trial: 20631694
Drug: Hydrocortisone (50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hydrocortisone (50 mg intravenously)
Trial: 17016794
Drug: Tolterodine treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tolterodine treatment for OAB over 12 weeks
Trial: 15661432
Drug: Granisetron (5‐HT3‐antagonist)
RxNorm normalized name: Granisetron
DrugBank: Granisetron (DB00889)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Granisetron (5‐HT3‐antagonist)
Trial: 15661432
Drug: Diclofenac‐sodium (PGE2‐antagonist)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Diclofenac‐sodium (PGE2‐antagonist)
Trial: 10213211
Drug: Low dose
RxNorm normalized name: Low Dose ASA
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low dose paclitaxel (135 mg/m2, 24-h i.v. infusion)
Trial: 10213211
Drug: High dose
RxNorm normalized name: INFLUENZA VACCINE HIGH DOSE 0.5ML SYR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High dose paclitaxel (250 mg/m2, 24-h i.v. infusion)
Trial: 10213211
Drug: Combined analysis
RxNorm normalized name: Chemicals and reagents for analysis
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combined analysis of paclitaxel concentrations from both treatment arms
Trial: 655675
Drug: Long term
RxNorm normalized name: BENZETHONIUM CHLORIDE 0.12 g in 100 mL TOPICAL SOLUTION [CA-REZZ - LONG TERM CARE - INCONTINENT CLEANSER]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Long term 5-FU administered after postoperative irradiations for gastric cancer
Trial: 655675
Drug: Levamisole as
RxNorm normalized name: Levamisole
DrugBank: Levamisole (DB00848)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Levamisole as adjuvant treatment for colon cancer
Trial: 655675
Drug: Chemotherapy in
RxNorm normalized name: menthol
DrugBank: Menthol (DB14123)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chemotherapy in advanced colon cancer
Trial: 655675
Drug: Preoperative radiotherapy
RxNorm normalized name: povidone-iodine
DrugBank: Povidone-iodine (DB06812)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Preoperative radiotherapy for rectal cancer
Trial: 655675
Drug: Chemotherapy as
RxNorm normalized name: menthol
DrugBank: Menthol (DB14123)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chemotherapy as a preoperative irradiation sensitizer in rectal cancer
Trial: 23559124
Drug: Salbutamol 800
RxNorm normalized name: Salbutamol
DrugBank: Albuterol (DB01001)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Salbutamol 800 µg
Trial: 19522395
Drug: Votalin Sustained
RxNorm normalized name: acetaminophen
DrugBank: Acetaminophen (DB00316)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Votalin Sustained Release Tablets
Trial: 18091987
Drug: 1.0% C31G
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1.0% C31G (SAVVY) gel
Trial: 8738073
Drug: i.v. meperidine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: i.v. meperidine 100 mg
Trial: 8738073
Drug: i.v. tramadol
FDA approved: no
EMA approved: no
PMDA approved: no
Description: i.v. tramadol 100 mg